Atlas One · Host Biology · Scale 07 — System

Hodgkin Lymphoma

Hodgkin lymphoma is a GC B cell-derived malignancy; RS cells ~100% CD30+; 9p24.1 amplification drives CD30+PD-L1/L2 co-expression; A+AVD (ECHELON-1) is standard for advanced stage; nivolumab/pembrolizumab for R/R; 5-year OS >85% overall; NLPHL has distinct CD20+ biology.

Also known as: Hodgkin lymphoma, HL, cHL, classical Hodgkin lymphoma, NLPHL, Reed-Sternberg, Hodgkin disease, nodular sclerosis HL, mixed cellularity HL

Scale 07 — SystemScale
draftStatus
2026-06-06Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
hodgkin-lymphoma

Hodgkin Lymphoma

Hodgkin lymphoma is a GC B cell-derived malignancy; RS cells ~100% CD30+; 9p24.1 amplification drives CD30+PD-L1/L2 co-expression; A+AVD (ECHELON-1) is standard for advanced stage; nivolumab/pembrolizumab for R/R; 5-year OS >85% overall; NLPHL has distinct CD20+ biology.